Eli Lilly Gets FDA Expanded Indication For Type 2 Diabetes Treatment Synjardy To Add Treatment-Naïve Adults

By: via Benzinga
Eli Lilly and Company (NYSE: LLY) disclosed that the FDA has approved an expanded indication for Synjardy (empagliflozin and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.